Nancy A Neilan

Summary

Affiliation: Children's Mercy Hospital

Country: USA

Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
Craig A Friesen
Department of Pediatrics, The Children s Mercy Hospital, 2401 Gillham Rd, Kansas City, Missouri, USA
BMC Res Notes 4:322. 2011
Useful biomarkers in pediatric eosinophilic duodenitis and their existence: a case-control, single-blind, observational pilot study
Nancy A Neilan
Section of Gastroenterology, Children s Mercy Hospital, Kansas City, MO 64108, USA
J Pediatr Gastroenterol Nutr 50:377-84. 2010
Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics
Craig A Friesen
The Children s Mercy Hospital and Clinics, Kansas City, Missouri, USA
BMC Gastroenterol 9:32. 2009

Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
Craig A Friesen
Department of Pediatrics, The Children s Mercy Hospital, 2401 Gillham Rd, Kansas City, Missouri, USA
BMC Res Notes 4:322. 2011
..abstract:..
Useful biomarkers in pediatric eosinophilic duodenitis and their existence: a case-control, single-blind, observational pilot study
Nancy A Neilan
Section of Gastroenterology, Children s Mercy Hospital, Kansas City, MO 64108, USA
J Pediatr Gastroenterol Nutr 50:377-84. 2010
..The aim of this study was to determine whether screening for food hypersensitivity could be a clinically useful biomarker for eosinophilic duodenitis in the pediatric population...
Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics
Craig A Friesen
The Children s Mercy Hospital and Clinics, Kansas City, Missouri, USA
BMC Gastroenterol 9:32. 2009
..The mechanism of this clinical response is unknown but could involve a decrease in eosinophil density or activation...